Elizabeth A. Guancial, M.D.

Elizabeth A. Guancial, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Office: (585) 275-9319
Fax: (585) 273-1042
Administrative: (585) 275-9319

Professional Bio

Dr. Guancial completed a Fellowship at the Dana Farber Cancer Institute. Prior to that, Elizabeth completed a residency in the Department of Internal Medicine at Massachusetts General Hospital. She earned her medical doctorate at Harvard Medical School, and an undergraduate degree from Hamilton College, where she graduated summa cum laude.

A former Buffalo resident, Elizabeth has significant experience in research related to bladder cancer and other GU cancers and was awarded a Bladder Cancer Research Award by the Bladder Cancer Advocacy Network. She currently serves as a peer reviewer for the European Oncology & Haematology journal and the British Journal of Urology.

Awards & Honors (Local)

Fellowship Teaching Award | Hematology Oncology Fellows 2015 - 2016

Recent Journal Articles

Showing the 5 most recent journal articles. 22 available »

2016 Aug
Mullane SA, Werner L, Guancial EA, Lis RT, Stack EC, Loda M, Kantoff PW, Choueiri TK, Rosenberg J, Bellmunt J. "Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma." Clinical genitourinary cancer. 2016 Aug; 14(4):352-9. Epub 0/24/2015.
2016 Aug
Loh KP, Mondo E, Hansen EA, Sievert L, Fung C, Sahasrabudhe DM, Guancial E. "Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma." Clinical genitourinary cancer. 2016 Aug; 14(4):e449-52. Epub 2016 Mar 24.
2016 Feb 10
Kilari D, Guancial E, Kim ES. "Role of copper transporters in platinum resistance." World journal of clinical oncology. 2016 Feb 10; 7(1):106-13.
Guancial EA, Kilari D, Xiao GQ, Abu-Farsakh SH, Baran A, Messing EM, Kim ES. "Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer." PloS one. 2016 11(5):e0155503. Epub 2016 May 17.
2015 Jun
Bellmunt J, Werner L, Bamias A, Fay AP, Park RS, Riester M, Selvarajah S, Barletta JA, Berman DM, de Muga S, Salido M, Gallardo E, Rojo F, Guancial EA, Bambury R, Mullane SA, Choueiri TK, Loda M, Stack E, Rosenberg J. "HER2 as a target in invasive urothelial carcinoma." Cancer medicine. 2015 Jun; 4(6):844-52. Epub 2015 Feb 26.

Current Appointments

Assistant Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary


Internal Medicine - American Board of Internal Medicine


MD | Harvard Medical School2006

Post-Doctoral Training & Residency

Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute07/01/2009 - 11/30/2012
Residency in Internal Medicine at Massachusetts General Hospital07/01/2007 - 06/30/2009
Internship in Internal Medicine at Massachusetts General Hospital07/01/2006 - 06/30/2007